Women's Fem Dophilus By Jarrow Formulas Overview & Drug Interactions

Check For Interactions With Women's Fem Dophilus

Supplement: Women's Fem Dophilus by Jarrow Formulas

Women's Fem Dophilus Label Images

supplement image

View and download

full size label image

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Women's Fem Dophilus by Jarrow Formulas

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Women's Fem Dophilus. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about Women's Fem Dophilus interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 790011030416

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Total Probiotic Blend
0 NP
Blend (non-nutrient/non-botanical) --
Lactobacillus rhamnosus, GR-1
0 NP
Lactobacillus rhamnosus
Lactobacillus reuteri, RC-14
0 NP
Lactobacillus reuteri

Other Ingredients:
Maltodextrin
Cellulose
Magnesium Stearate
Capsule
Forms
  • Hydroxypropylmethylcellulose
  • Titanium Dioxide


Label Statments:


Suggested/Recommended/Usage/Directions
- Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.
- If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Brand IP Statement(s)
- Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.
- 2018 Jarrow Formulas
- RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S.
Precautions
- Keep out of the reach of children.
- If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Formulation
- Suitable for Vegetarians/Vegans
- Free of major allergens
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
- Strains matter Jarrow Forumlas' probiotics contain clinically documented strains
- A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
- Minimum 1 billion viable cells at time of consumption, under recommended storage conditions and within best used before date.
- Gluten free
- Vegan
- Made in Denmark by Chr. Hansen A/S
FDA Statement of Identity
- Oral Probiotic Supplement
Formula
- Vaginal/urinary tract health
- GR-1/RC-14 and vaginal flora (also called microbiota)
- Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health.
Storage
- No refrigeration necessary
- Fem-Dophilus does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77 degrees F (25 degrees C).
- New shelf stable
General Statements
- In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement. GR-1/RC-14 75% Control Group 34% Martinez, et al. Can J Microbiol 2009;55:133-138 25+ years of GR-1/RC-14 research/clinical studies 1988 First Research on GR-1/RC-14 Strains Begin 27 Clinical Studies Published Between 2001 and 2014 2006 Fem-Dophilus Introduced (2006)
- 25+ years of research/clinical studies
Seals/Symbols
- Veggie caps

Brand Information

See all products by this brand

Distributed exclusively by
Name Jarrow Formulas Superior Nutrition and Formulation
Street Address P.O. Box 35994
City Los Angeles
State CA
ZipCode 90035-4317
Web Address www.Jarrow.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.